Alex Howarth
Equibles does not estimate personal net worth.
About Alex Howarth
Alex Howarth was last confirmed as CFO at Madrigal Pharmaceuticals, Inc. (MDGL) in a filing dated April 29, 2024. The proxy statement of Madrigal Pharmaceuticals, Inc. reports total compensation of $5,262,023 for Alex Howarth in fiscal 2023, including a base salary of $498,829. Disclosed compensation is on record for 3 fiscal years. Alex Howarth has spoken on 1 earnings call across 1 company, most recently for Madrigal Pharmaceuticals, Inc. on May 9, 2022. The companies whose calls Alex Howarth spoke on are classified in the Healthcare sector.
Alex Howarth on recent calls
“Based on our cash position and term loan facility announced today, Madrigal is on solid financial footing for the road ahead. As of March 31, 2022, Madrigal had cash, cash equivalents and marketable securities of $220 million compared to $270.3 million at December 31, 2021.”
Affiliation history
-
Start not stated–2024-04-29
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Madrigal Pharmaceuticals, Inc. (MDGL) | Former Senior Vice President and Chief Financial Officer | $498,829 | $5,262,023 |
| 2022 | Madrigal Pharmaceuticals, Inc. (MDGL) | Former Senior Vice President and Chief Financial Officer | $465,625 | $3,482,906 |
| 2021 | Madrigal Pharmaceuticals, Inc. (MDGL) | Former Senior Vice President and Chief Financial Officer | $281,250 | $7,131,804 |